Caricamento...
Sonidegib for the Treatment of Advanced Basal Cell Carcinoma
Basal cell carcinoma (BCC) accounts for almost 80% of skin cancers, and its healthcare workload burden is substantial within dermatology departments. Although most BCCs are small, well-defined tumors amenable of surgery or conservative procedures, in a small proportion of patients, BCCs can progress...
Salvato in:
| Pubblicato in: | Front Oncol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7662670/ https://ncbi.nlm.nih.gov/pubmed/33194718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.582866 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|